Establishment Labs Holdings (ESTA) Depreciation & Amortization (CF) (2018 - 2022)
Establishment Labs Holdings' (ESTA) quarterly Depreciation & Amortization (CF) came in at $24000.0 in Q2 2022, down 25.0% year-on-year from $32000.0 in Q2 2021, and down 4.0% quarter-over-quarter from $25000.0 in Q1 2022.
Establishment Labs Holdings (ESTA) Depreciation & Amortization (CF) (2018 - 2022) Analysis & Trends
Establishment Labs Holdings' Depreciation & Amortization (CF) history runs 5 years deep, the most recent figure standing at $24000.0 for Q2 2022.
- On a quarterly basis, Depreciation & Amortization (CF) fell 25.0% year-over-year to $24000.0 in Q2 2022; TTM through Mar 2023 was $24000.0, a 72.41% decrease from a year earlier, with the FY2019 full-year figure at $84000.0, down 6.56% from the prior year.
- Depreciation & Amortization (CF) retreated to $24000.0 in Q2 2022 per ESTA's latest filing, from $25000.0 in the prior quarter.
- Across five years, Depreciation & Amortization (CF) topped out at $43000.0 in Q1 2021 and bottomed at $20000.0 in Q1 2020.
- The 5-year median for Depreciation & Amortization (CF) is $21000.0 (2018), against an average of $24306.2.
- Across the five-year window, Depreciation & Amortization (CF) soared 115.0% in 2021 and slumped 41.86% in 2022, its largest moves.
- Year by year, Depreciation & Amortization (CF) stood at $20900.0 in 2018, then rose by 0.48% to $21000.0 in 2019, then dropped by 4.76% to $20000.0 in 2020, then surged by 50.0% to $30000.0 in 2021, then dropped by 20.0% to $24000.0 in 2022.
- Per Business Quant, the three latest ESTA Depreciation & Amortization (CF) figures stand at $24000.0 (Q2 2022), $25000.0 (Q1 2022), and $30000.0 (Q3 2021).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 381.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 120.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 716.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 351.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 40.90 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 67.10 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 310.25 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 78.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Establishment Labs Holdings | 2.73 Bn | 2.66 Bn | 42.34 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | 24,000.00 |
| Jun 30, 2022 | 24,000.00 |
| Mar 31, 2022 | 25,000.00 |
| Mar 31, 2022 | 25,000.00 |
| Sep 30, 2021 | 30,000.00 |
| Sep 30, 2021 | 30,000.00 |
| Jun 30, 2021 | 32,000.00 |
| Jun 30, 2021 | 32,000.00 |
| Mar 31, 2021 | 43,000.00 |
| Mar 31, 2021 | 43,000.00 |
| Sep 30, 2020 | 20,000.00 |
| Sep 30, 2020 | 20,000.00 |
| Jun 30, 2020 | 21,000.00 |
| Jun 30, 2020 | 21,000.00 |
| Mar 31, 2020 | 20,000.00 |
| Mar 31, 2020 | 20,000.00 |
| Dec 31, 2019 | 21,000.00 |
| Dec 31, 2019 | 21,000.00 |
| Sep 30, 2019 | 21,000.00 |
| Sep 30, 2019 | 21,000.00 |